Clincosm LogoSign in Get a demo

Prostate Cancer

Showing NaN - NaN of 158
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in United States (Docetaxel-PNP, Ribociclib, Prednisone)

Completed
Has Results
  • Prostate Cancer
  • San Francisco, California
  • +5 more
Aug 9, 2022

Prostate Cancer Trial in San Francisco, Saint Louis (Ibrutinib, Blood samples for PSA and immune assays, Radical prostatectomy)

Recruiting
  • Prostate Cancer
  • San Francisco, California
  • +1 more
Aug 15, 2022

Precision-Based Genomics in Prostate Cancer

Recruiting
  • Prostate Cancer
    • La Jolla, California
    • +4 more
    Jul 28, 2022

    Prostate Cancer, Advanced Prostate Carcinoma Trial in San Francisco (Hyperpolarized C13, Magnetic Resonance Imaging (MRI))

    Recruiting
    • Prostate Cancer
    • Advanced Prostate Carcinoma
    • Hyperpolarized C13
    • Magnetic Resonance Imaging (MRI)
    • San Francisco, California
      University of California, San Francisco
    Jul 27, 2022

    Prostate Cancer, Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in San Francisco

    Recruiting
    • Prostate Cancer
    • +2 more
    • Consultation audio recording app
    • San Francisco, California
      University of California, San Francisco
    Jul 27, 2022

    Prostate Cancer Trial in Worldwide (capivasertib, docetaxel, )

    Recruiting
    • Prostate Cancer
    • Phoenix, Arizona
    • +203 more
    Jul 27, 2022

    Glioblastoma, Melanoma Stage IV, Melanoma Recurrent Trial in United Kingdom, United States (ST101)

    Recruiting
    • Glioblastoma
    • +11 more
    • San Francisco, California
    • +11 more
    Jul 13, 2022

    Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

    Recruiting
    • Ovarian Cancer
    • +12 more
    • San Francisco, California
    • +44 more
    Jul 12, 2022

    Prostate Cancer Trial in United States (Invitae multi-cancer gene panel)

    Completed
    • Prostate Cancer
    • Invitae multi-cancer gene panel
    • San Diego, California
    • +18 more
    Jul 1, 2022

    Mechanisms of Resistance to PSMA Radioligand Therapy

    Recruiting
    • Prostate Cancer
    • Single-photon emission computed tomography
    • +2 more
    • Los Angeles, California
    • +2 more
    Jun 22, 2022

    Prostate Cancer, Advanced Prostate Carcinoma Trial in San Francisco (Participant Surveys, Mobile app)

    Recruiting
    • Prostate Cancer
    • Advanced Prostate Carcinoma
    • Participant Surveys
    • Mobile app
    • San Francisco, California
      San Francisco Veterans Affairs Medical Center
    Jun 22, 2022

    Analyzing Clinical Trial Experiences of Prostate Cancer Patients

    Not yet recruiting
    • Prostate Cancer
      • San Francisco, California
        Power Life Sciences
      Jun 14, 2022

      Prostate Cancer Trial in Canada, United States (Casodex, Eulexin, LHRH agonist)

      Completed
      Has Results
      • Prostate Cancer
      • Birmingham, Alabama
      • +260 more
      May 23, 2022

      Prostate Cancer Trial in Canada, United States (bicalutamide, radiation therapy, )

      Completed
      Has Results
      • Prostate Cancer
      • Birmingham, Alabama
      • +239 more
      May 23, 2022

      Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco (FOR46, Enzalutamide, Pegfilgrastim)

      Recruiting
      • Metastatic Castration-resistant Prostate Cancer
      • Prostate Cancer
      • FOR46
      • +2 more
      • San Francisco, California
        University of California, San Francisco
      Jun 1, 2022

      Prostate Cancer Trial in San Francisco (Pyruvate (13C), Hyperpolarized 13C,15N2-urea, Magnetic Resonance Spectroscopic Imaging)

      Active, not recruiting
      • Prostate Cancer
      • Pyruvate (13C)
      • +2 more
      • San Francisco, California
        University of California, San Francisco
      May 16, 2022

      Prostate Cancer Trial in San Francisco (CTT1403, CTT1057, 68Ga-PSMA-11)

      Active, not recruiting
      • Prostate Cancer
      • San Francisco, California
        University of California, San Francisco
      Apr 14, 2022

      Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in San Francisco (drug, biological, procedure)

      Recruiting
      • Prostate Cancer
      • Metastatic Castration-resistant Prostate Cancer
      • San Francisco, California
        University of California, San Francisco
      Mar 29, 2022

      Small Cell Neuroendocrine Carcinoma, Prostate Cancer, Small Cell Carcinoma Trial in San Francisco (Apalutamide, Cetrelimab)

      Recruiting
      • Small Cell Neuroendocrine Carcinoma
      • +2 more
      • San Francisco, California
        University of California, San Francisco
      Mar 21, 2022

      Prostate Cancer, Castration Resistant Prostate Cancer Trial in United States (Enzalutamide, CC-115)

      Active, not recruiting
      • Prostate Cancer
      • Castration Resistant Prostate Cancer
      • San Francisco, California
      • +4 more
      Mar 18, 2022

      Prostate Cancer Trial in Canada, United States (Radiation Therapy, Enzalutamide, Bicalutamide)

      Recruiting
      • Prostate Cancer
      • Radiation Therapy
      • +3 more
      • Gilbert, Arizona
      • +107 more
      Mar 17, 2022

      Prostate Cancer Trial in Worldwide (AMG 509, Abiraterone, Enzalutamide)

      Recruiting
      • Prostate Cancer
      • AMG 509
      • +2 more
      • Duarte, California
      • +18 more
      Mar 17, 2022

      Prostate Cancer Trial in United States (GnRH, Bicalutamide, Salvage radiation)

      Active, not recruiting
      • Prostate Cancer
      • San Diego, California
      • +7 more
      Mar 7, 2022

      Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

      Terminated
      • Mesothelioma
      • +12 more
      • MGD009
      • Los Angeles, California
      • +19 more
      Feb 4, 2022

      Castration-resistant Prostate Cancer, Metastatic Prostate Cancer, Prostate Cancer Trial in San Francisco, Baltimore, Boston

      Active, not recruiting
      • Castration-resistant Prostate Cancer
      • +2 more
      • San Francisco, California
      • +2 more
      Nov 16, 2021